ENDRA Life Sciences Inc. - stock earnings
NDRA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -3.1 million USD | ? USD |
2023Q2 | -2.6 million USD | ? USD |
2023Q1 | -2.9 million USD | ? USD |
2022Q4 | -3.3 million USD | ? USD |
2022Q3 | -3.5 million USD | ? USD |
2022Q2 | -3.6 million USD | ? USD |
2022Q1 | -2.9 trillion USD | ? USD |
2021Q4 | -3.1 million USD | ? USD |
2021Q3 | -2.7 million USD | ? USD |
2021Q2 | -3.2 million USD | ? USD |
2021Q1 | -2.3 million USD | ? USD |
2020Q4 | -2.3 million USD | ? USD |
2020Q3 | -3.3 million USD | ? USD |
2020Q2 | -2.9 million USD | ? USD |
2020Q1 | -3.3 million USD | ? USD |
2019Q4 | -4.8 million USD | ? USD |
2019Q3 | -3.4 million USD | ? USD |
2019Q2 | -2.3 million USD | ? USD |
2019Q1 | -2.7 million USD | ? USD |
2018Q4 | -2.4 million USD | ? USD |
2018Q3 | -2.8 million USD | ? USD |
2018Q2 | -1.8 million USD | 6174 USD |
2018Q1 | -2.8 million USD | 6174 USD |
2017Q4 | -2.3 million USD | 6850 USD |
2017Q3 | -908908 USD | 287000 USD |
2017Q2 | -1.4 million USD | 57772 USD |
2017Q1 | -741623 USD | ? USD |
2016Q4 | -686878 USD | 515582 USD |
2016Q3 | -979899 USD | ? USD |
2016Q2 | -729114 USD | ? USD |
2016Q1 | -379478 USD | ? USD |
2015Q4 | -458733 USD | 254999 USD |
2015Q3 | -540987 USD | 326085 USD |
2015Q2 | ? USD | 829000 USD |
2014Q4 | -2.2 million USD | 559000 USD |
NDRA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -11.9 million USD | ? USD |
2022 | -13.2 million USD | ? USD |
2021 | -11.2 million USD | ? USD |
2020 | -12.0 million USD | ? USD |
2019 | -15.6 million USD | ? USD |
2018 | -9.8 million USD | 6174 USD |
2017 | -5.4 million USD | 351622 USD |
2016 | -2.8 million USD | 515582 USD |
2015 | -2.3 million USD | 1.4 million USD |
2014 | -2.2 million USD | 559355 USD |
NDRA
Price: $0.33
52 week price:
Earnings Per Share: -2.56 USD
P/E Ratio: -0.46
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 4700
Ebitda: -2.3 millionMarket Capitalization: 3.9 million